SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

GENFIT SA - €36.3 MILLION IN REVENUE FOR THE FIRST NINE MONTHS OF 2026 FROM ROYALTIES ON IPSEN’S SALES OF IQIRVO (ELAFIBRANOR), AN INCREASE

GENFIT SA - €36.3 MILLION IN REVENUE FOR THE FIRST NINE MONTHS OF 2026 FROM ROYALTIES ON IPSEN’S SAL

SA

Related stories